Answers are grounded in this paper and cite their sources.
The myosin light chain kinase inhibitor, wortmannin (WT), caused dose-dependent inhibition of the sustained increases but not the initial spikes of inositol 1,4,5-trisphosphate (Ins-1,4,5-P3) and cytoplasmic Ca2+ concentration ([Ca2+]i) in angiotensin II (AII)-stimulated adrenal glomerulosa cells. In contrast, WT did not affect the [Ca2+]i increases evoked by K(+)-induced depolarization or by depletion of intracellular Ca2+ stores with ionomycin or thapsigargin, suggesting that its inhibitory effects on Ins-1,4,5-P3 and [Ca2+]i responses are closely related. The inhibitory effect of WT on the Ins-1,4,5-P3 response was not secondary to its reduction of Ca2+ entry, since ionomycin-induced elevation of [Ca2+]i did not restore Ins-1,4,5-P3 formation. Also, WT inhibited agonist- and GTP gamma S-stimulated Ins-1,4,5-P3 formation in permeabilized cells maintained at fixed Ca2+ concentrations. Thus, inhibition of Ca2+ influx by WT is a consequence of reduced Ins-1,4,5-P3 formation and could reflect the resultant refilling of the agonist-sensitive Ca2+ pool. Indeed, AII-depleted Ca2+ pools were found to refill by a thapsigargin-sensitive mechanism in WT-treated cells. Other structurally unrelated inhibitors of myosin light chain kinase (MS-347a, KT5926, and ML-9) also inhibited AII-induced inositol phosphate formation, albeit with lower potencies than WT. MS-347a, like WT, inhibited only the second phase of the inositol phosphate and [Ca2+]i responses to AII. These findings demonstrate that WT is a potent inhibitor of the Ins-1,4,5-P3-Ca2+ signaling pathway and acts primarily on a mechanism that promotes Ins-1,4,5-P3 formation and is sensitive to inhibitors of myosin light chain kinase activity.
No takes yet. Share an insight, caveat, or question.
Nakanishi et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: